Immunocore Holdings Plc (IMCR)
33.68
+0.75
(+2.28%)
USD |
NASDAQ |
Feb 24, 16:00
33.72
+0.04
(+0.12%)
After-Hours: 20:00
Immunocore Holdings Profit Margin (Quarterly) : -0.17% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Silence Therapeutics Plc | -13.18K% |
| Adaptimmune Therapeutics Plc | -221.8% |
| Biodexa Pharmaceuticals Plc | -- |
| Oxford Biomedica Plc | -- |
| NuCana Plc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -7.65% |
| Return on Assets | -2.74% |
| Return on Invested Capital | -3.53% |
| Gross Profit Margin (Quarterly) | 98.74% |
| Operating Margin (Quarterly) | -6.92% |
| Return on Net Operating Assets | -23.53% |